Sunshine Biopharma Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $64.4K
Liabilities Breakdown FY2016
Total Liabilities: $274.1K
Asset Breakdown
Total Assets: $64.4K
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $57.5K | 89.2% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $5.9K | 9.2% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.0K | 1.6% |
Liabilities Breakdown
Total Liabilities: $274.1K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $28.1K | 10.3% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $246.0K | 89.7% |